First Financial: Earnings Fuel Rising Potential, Buy
seekingalpha.com
Want to monitor HUMA?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor HUMAHumacyte, Inc. , is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions.